Atlas Trials

Modified Conditioning Regimen for CML-BP

Clinical trial NCT07259161 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07259161
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
CML,Blast PhaseHSCT
Start date
2025-12-15
Primary completion
2029-09-14
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.